CNPase, a 2′,3′-Cyclic-nucleotide 3′-phosphodiesterase, as a Therapeutic Target to Attenuate Cardiac Hypertrophy by Enhancing Mitochondrial Energy Production

Heart failure is the end-stage of all cardiovascular diseases with a ~25% 5-year survival rate, and insufficient mitochondrial energy production to meet myocardial demand is the hallmark of heart failure. Mitochondrial components involved in the regulation of ATP production remain to be fully elucid...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Keai Sinn, Wang, Dongfang, Lu, Ziqiang, Zhang, Yihan, Li, Sixu, Lin, Yue, Tan, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509266/
https://www.ncbi.nlm.nih.gov/pubmed/34639145
http://dx.doi.org/10.3390/ijms221910806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509266/
https://www.ncbi.nlm.nih.gov/pubmed/34639145
http://dx.doi.org/10.3390/ijms221910806

Ejemplares similares